Evidence map›Paper›PMID 28653989›Full record

ReviewInternational journal of molecular sciences2017

Allergens with Protease Activity from House Dust Mites.

Manuel Reithofer, Beatrice Jahn-Schmid

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 100 citations in OpenAlex.

  1. Metabolites · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Molecular allergen sensitization drives phenotypes of severe asthma in children: Evidence from a megacity cohort (SAMP).Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology · 2024
    Article
  11. Article
  12. Article
  13. Article
  14. ATP functions as a primary alarmin in allergen-induced type 2 immunity.American journal of physiology. Cell physiology · 2023
    Review
  15. Dissecting Airborne Allergens.Journal of clinical medicine · 2023
    Review
  16. Article
  17. Advanced In Vitro Three-Dimensional Skin Models of Atopic Dermatitis.Tissue engineering and regenerative medicine · 2023
    Review
  18. Article
  19. Neuroimmune interactions in atopic and allergic contact dermatitis.The Journal of allergy and clinical immunology · 2023
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Manuel ReithoferInstitute of Pathophysiology and Allergy Research, Medical University of Vienna, Vienna 1090, Austria. manuel.reithofer@meduniwien.ac.at.
Beatrice Jahn-SchmidInstitute of Pathophysiology and Allergy Research, Medical University of Vienna, Vienna 1090, Austria. beatrice.jahn-schmid@meduniwien.ac.at.
Medical University of Vienna · AT

Funding

Austrian Science Fund FWF W 1248
6 · The paper itself

Abstract

Globally, house dust mites (HDM) are one of the main sources of allergens causing Type I allergy, which has a high risk of progressing into a severe disabling disease manifestation such as allergic asthma. The strong protease activities of a number of these allergens are thought to be involved in several steps of the pathophysiology of this allergic disease. It has been a common notion that protease activity may be one of the properties that confers allergenicity to proteins. In this review we summarize and discuss the roles of the different HDM proteases in the development of Type I allergy.

Indexed as

AllergensAnimalsArthropod ProteinsEpitheliumHumansHypersensitivityImmunity, CellularImmunoglobulin ELungPeptide HydrolasesPyroglyphidaeTh1 CellsTh2 CellsAllergensArthropod ProteinsImmunoglobulin EPeptide HydrolasesallergenDer p 1house dust miteprotease

Identifiers

PMID28653989
PMCPMC5535861
OpenAlexW2730402578

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.